Does neuroprotection improve stroke outcome?
Lees
K R
KR
Acute Stroke Unit, Western Infirmary, Glasgow, UK.
D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D013844:Thiazoles / Q000627:therapeutic use*; D015912:Thrombolytic Therapy; D013997:Time Factors; D016896:Treatment Outcome
D018696:Neuroprotective Agents; D010880:Piperidines; D013844:Thiazoles; C097722:lubeluzole